August 6, 2011 -- Shionogi will pay $185 million to obtain a controlling interest in C&O Pharma of China; Hebei Changshan Biochemical Pharma hopes to raise $117 million in a ChiNext IPO; Global Pharm Holdings paid $9 million to acquire drug distributor Shandong Hua Wei; Zhejiang Hisun Pharma will spend $2 million to buy a 25% stake in US-based PharmTak; VWR of the US announced plans to acquire LabPartner (Shanghai) Company; Simcere Pharma will increase its R&D staff to 1,000 within four years, up from 300 currently; BGI of Shenzhen and GT Life Sciences of San Diego published their genomic sequence of the Chinese hamster ovary K1 cell line; and Merck will be cutting another 13,000 jobs around the world while increasing its China workforce. More details….
Stock Symbols: (TO: 8053) (SHE: 300255) (OTCBB: GPHG) (SHA: 600267) (NYSE: SCR) (NYSE: MRK)
